The underlying mechanism behind this positive correlation between SIRT5 and VSNL1 expression in glioma samples deserves further investigation by utilizing, for example, transgenic SIRT5-knockout mouse models to examine the interactions between SIRT5 and synapse-related pathways and its impacts on glioma development and invasion [41]. Here, VSNL1 is linked to central nervous system cancer.